Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Immune Function

Research synthesisVery low evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported small beneficial effects of Lactobacillus brevis SBC8803 on immune function, specifically enhancements in natural killer (NK) cell activity and secretory IgA levels. The evidence base is very small (only 3 studies, all reviews) and no study reported statistical significance or specific dose/duration data. No single population or dose range was consistently studied.

  • Studied populations: patients with psoriasis

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All included studies are reviews, not primary trials, and none reported statistical significance. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). No dose, duration, or form data were extractable, limiting practical applicability.

Generated May 12, 2026
3 of 3 papers
Back to top